Download Free Sample Report

Psychedelic Drugs Market, Global Outlook and Forecast 2023-2030

Psychedelic Drugs Market, Global Outlook and Forecast 2023-2030

  • Published on : 15 November 2023
  • Pages :118
  • Report Code:SMR-7849443

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

This report aims to provide a comprehensive presentation of the global market for Psychedelic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychedelic Drugs. This report contains market size and forecasts of Psychedelic Drugs in global, including the following market information:
Global Psychedelic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Psychedelic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Psilocybin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Psychedelic Drugs include COMPASS Pathways PLC, Pfizer, Eli Lilly, GlaxoSmithKline, Cybin Inc, Field Trip Health, ATAI Life Sciences, NUMINUS WELLNESS and MindMed, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psychedelic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychedelic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Psychedelic Drugs Market Segment Percentages, by Type, 2022 (%)
Psilocybin
LSD
MDMA
DMT
Ketamine
Others
Global Psychedelic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Psychedelic Drugs Market Segment Percentages, by Application, 2022 (%)
Depressive Disorders
Post-Traumatic Stress Disorders
Substance Abuse Disorders
Obsessive Compulsive Disorders
Others
Global Psychedelic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Psychedelic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychedelic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Psychedelic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
COMPASS Pathways PLC
Pfizer
Eli Lilly
GlaxoSmithKline
Cybin Inc
Field Trip Health
ATAI Life Sciences
NUMINUS WELLNESS
MindMed
HAVN Life Sciences
Seelos Therapeutics
Jannsen
Acadia Pharmaceuticals
Intellipharmaceutics
Revive Therapeutics
Mydecine Innovations Group
Red Light Holland
Braxia Scientific
Mind Cure Health
Entheon Biomedical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Psychedelic Drugs, market overview.
Chapter 2: Global Psychedelic Drugs market size in revenue.
Chapter 3: Detailed analysis of Psychedelic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Psychedelic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.